
Osama Mosalem, MD
@osamamosalemmd
Hematology Oncology fellow @MayoClinic Florida, @michiganstateU @msu_medicine @CairoUniversity alumni. Father and Husband 🧑🧑🧒🧒🇺🇸🇪🇬
ID: 1311112239097753601
30-09-2020 01:15:15
289 Tweet
648 Followers
447 Following



Genomic Alterations in DNA Mismatch Repair Genes Across Different Cancer Types JCO Precision Oncology doi.org/10.1200/PO-24-… ❓How do identify dMMR pts 👉33.8% pts with MMR mutations have MMR loss 👉only 34% of pts with MMR loss had MMR mutations 👉we need both NGS & IHC testing❗️ ESMO - Eur. Oncology



Comparison of 1st chemotherapy in unresectable locally advanced or metastatic #PDAC The Lancet Oncology doi.org/10.1016/S1470-… 🔎systematic review & Bayesian network meta-analysis, 79 trials, 22 168 pts 👉NALIRIFOX & FOLFIRINOX may be the preferred options if feasible ESMO - Eur. Oncology


🔥ACRO ROVER- Upper GI🔥 Localized Esophagus Adenocarcinoma in 5 minutes, Check it out! ACROresident ACRO - American College of Radiation Oncology ROVERRO ARRO Mayo Clinic Radiation Oncology Dr. Nina Niu Sanford 1/



#GI25 More about the immunotherapy BOT/BAL.🙌🏽 ✔️Neoadjuvant: 1️⃣🪺NEST➡️BOT/BAL 2️⃣🦄 UNICORN➡️BOT➕/➖BAL ✔️Metastatic: Dr. Marwan G. Fakih City of Hope 3️⃣BOT➕/➖BAL ➕Combinations 4️⃣FOLFOX-3B (BEV+BOT+BAL) 5️⃣iNKT🔵+RAM+TAX+ BOT+BAL Colorectal Cancer Alliance 2024 Advancements OncoAlert ASCO #CRCSM





Masterclass presentation on the management of advanced colorectal cancer from Tanios Bekaii-Saab, MD at the inaugural Mayo Clinic Heme/Onc Board Review and Practice Update conference this week. Can he fit it in one slide...? He sure can! Don't miss this next year. tinyurl.com/rh7c927c


Hematologic dysfunction and myeloid neoplasm risk in patients treated with lutetium-177 prostate specific membrane antigen therapy pubmed.ncbi.nlm.nih.gov/40176753/ #Lutetium #CH #PPM1D #TP53 #prostate yael kusne MD PhD Mayo Clinic Comprehensive Cancer Center

🚨 Hot off the press! 🚨 The ESMO - Eur. Oncology Precision Oncology Working Group, led by the amazing Ben Westphalen G Curigliano MD PhD has unveiled key "Recommendations for structuring Molecular Tumour Boards (MTBs) in clinical practice", now published in ESMO's flagship journal Annals of Oncology



Trying to summarize nuanced treatment decisions in one slide... What to do with small NF-pNETs? Who to observe? When to intervene...? What am I missing/getting wrong...? Paging my surgery friends Julie Hallet Stefano Partelli Callisia Clarke MD Patrick Starlinger_TELL International Cornelius A. Thiels Sean Cleary


🦓 NANETS is going to LA ⭐️🍿🎥 If you’re around and want to learn more about #NETs, join us! I’ll be there along with Thor Halfdanarson Callisia Clarke MD Jess Maxwell MD MBA Laleh Melstrom & many more 📆 May 17 🔗 nanets.net/component/civi… Thanks Alexandra Gangi, MD for organizing!


Big week for #GIcancers, Nivo + Ipi gets FDA approved for HCC #livercancer, just a few days after the same regimen got approval in MSI-H #coloncancer. #CheckMate9DW ascopubs.org/doi/10.1200/JC… #Chekmate8HW nejm.org/doi/full/10.10… OncoAlert Oncology Brothers OncLive.com GI Oncology Now



Wishing you all the best! Mohamed Ali